| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(09)60938-7 |
| P698 | PubMed publication ID | 19683340 |
| P50 | author | Francis Ka-Ming Chan | Q42153384 |
| P2093 | author name string | Peter Malfertheiner | |
| Kenneth E L McColl | |||
| P2860 | cites work | Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself? | Q22306448 |
| Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials | Q24546221 | ||
| The role of gastrin in ulcer pathogenesis | Q73629005 | ||
| Cure of Helicobacter pylori-associated ulcer disease through eradication | Q73629031 | ||
| The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori-infected healthy subjects | Q74036159 | ||
| Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production | Q74531603 | ||
| Clinical and endoscopic characteristics of non-Helicobacter pylori, non-NSAID duodenal ulcers: a long-term prospective study | Q77331394 | ||
| A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer | Q77331416 | ||
| Current or recent proton pump inhibitor therapy markedly impairs the accuracy of the [14C]urea breath test | Q77608865 | ||
| Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study | Q77769244 | ||
| Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies | Q77923132 | ||
| Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial | Q79676511 | ||
| Genetic polymorphisms of NOD1 and IL-8, but not polymorphisms of TLR4 genes, are associated with Helicobacter pylori-induced duodenal ulcer and gastritis | Q79798187 | ||
| Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs | Q81248684 | ||
| Interaction between IL1B gene promoter polymorphisms in determining susceptibility to Helicobacter pylori associated duodenal ulcer | Q82896112 | ||
| Amino terminus and the first four membrane-spanning segments of the Arabidopsis K+ channel KAT1 confer inward-rectification property of plant-animal chimeric channels | Q95805985 | ||
| Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report | Q24674636 | ||
| Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen | Q28164178 | ||
| Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review | Q28194969 | ||
| Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials | Q28200013 | ||
| Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study | Q28200506 | ||
| Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use? | Q28201393 | ||
| Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial | Q28210388 | ||
| Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review | Q28212850 | ||
| Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding | Q28213463 | ||
| Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial | Q28216474 | ||
| Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations | Q28217824 | ||
| Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment | Q28218361 | ||
| Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population | Q28218399 | ||
| A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women | Q28218670 | ||
| Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications | Q28219448 | ||
| Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants | Q28219972 | ||
| Cure of duodenal ulcer associated with eradication of Helicobacter pylori | Q28256637 | ||
| Unidentified curved bacilli on gastric epithelium in active chronic gastritis | Q28261151 | ||
| Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration | Q29547429 | ||
| Causes underlying the birth-cohort phenomenon of peptic ulcer: analysis of mortality data 1911-2000, England and Wales | Q31041312 | ||
| Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study | Q33175376 | ||
| Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication | Q33302739 | ||
| Guidelines for prevention of NSAID-related ulcer complications | Q33412100 | ||
| Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia | Q33619704 | ||
| Should non-invasive Helicobacter pylori testing replace endoscopy in investigation of dyspepsia? | Q33903435 | ||
| Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study | Q34009506 | ||
| ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice g | Q34154695 | ||
| Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis | Q34247727 | ||
| Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase | Q34252248 | ||
| Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer | Q34377376 | ||
| Gastrin and somatostatin in Helicobacter pylori infected antral mucosa | Q34378628 | ||
| Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers | Q34393522 | ||
| Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole | Q34407809 | ||
| Relation between gastric acid output, Helicobacter pylori, and gastric metaplasia in the duodenal bulb | Q34410052 | ||
| Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. | Q51565479 | ||
| Helicobacter pylori infection and exaggerated gastrin release. Effects of inflammation and progastrin processing. | Q51599679 | ||
| In vivo assessment of the gastric mucosal tolerance dose after single fraction, small volume irradiation of liver malignancies by computed tomography-guided, high-dose-rate brachytherapy. | Q52932463 | ||
| Patterns of inflammation linked to ulcer disease | Q56157321 | ||
| CIVILISATION AND PEPTIC ULCER*1 | Q56830457 | ||
| Stress ulcer prophylaxis in mechanically ventilated patients: integrating evidence and judgment using a decision analysis | Q56929040 | ||
| Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs | Q57945428 | ||
| Potent ulcerogenic actions of platelet-activating factor on the stomach | Q59065369 | ||
| H. pylori-negative duodenal ulcer prevalence and causes in 774 patients | Q59509874 | ||
| Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers | Q61570355 | ||
| The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer | Q61960636 | ||
| The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies | Q61960641 | ||
| Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patients with duodenal ulcer | Q63409765 | ||
| Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs | Q67903664 | ||
| Plasma Gastrin, Daytime Intragastric pH, and Nocturnal Acid Output before and at 1 and 7 Months after Eradication ofHelicobacter pyloriin Duodenal Ulcer Subjects | Q67917465 | ||
| Blood lymphocyte proliferation, cytokine secretion and appearance of T cells with activation surface markers in cultures with Helicobacter pylori. Comparison of the responses of subjects with and without antibodies to H. pylori | Q67984886 | ||
| The mucoid cap over superficial gastric damage in the rat. A high-pH microenvironment dissipated by nonsteroidal antiinflammatory drugs and endothelin | Q68523385 | ||
| Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection | Q70525503 | ||
| Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration | Q70912581 | ||
| A mechanism by which Helicobacter pylori infection of the antrum contributes to the development of duodenal ulcer | Q71035846 | ||
| Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease | Q72114814 | ||
| Salicylate Damage to the Gastric Mucosal Barrier | Q72219865 | ||
| Helicobacter pylori infection: genetic and environmental influences. A study of twins | Q72424515 | ||
| Demonstration of a phospholipid-rich zone in the human gastric epithelium damaged by Helicobacter pylori | Q72638584 | ||
| Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial | Q72669446 | ||
| Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs | Q72674958 | ||
| Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease | Q72715711 | ||
| Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro | Q41392086 | ||
| The clinical relevance of strain types of Helicobacter pylori | Q41552242 | ||
| Asymptomatic peptic ulcer disease | Q42559696 | ||
| Gastric mucosal barrier: evidence for Helicobacter pylori ingesting gastric surfactant and deriving protection from it. | Q43212856 | ||
| Healing of duodenal ulcer after eradication of Helicobacter heilmannii. | Q43997322 | ||
| Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice. | Q44077396 | ||
| Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease -- results from a randomized trial programme | Q44105244 | ||
| Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis | Q44165133 | ||
| Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment | Q44214971 | ||
| Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease | Q44215910 | ||
| Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis | Q44261800 | ||
| Contribution of HLA-DQA gene to host's response against Helicobacter pylori | Q44266538 | ||
| Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs | Q44443132 | ||
| Second‐line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies | Q44611978 | ||
| The importance of biopsychosocial factors in the development of duodenal ulcer in a cohort of middle-aged men | Q44743485 | ||
| Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial. | Q45104115 | ||
| Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients | Q45219635 | ||
| Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial | Q46099612 | ||
| A prospective study of gastric and duodenal ulcer and its relation to smoking, alcohol, and diet | Q46327283 | ||
| Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients | Q46604034 | ||
| Clinical trial: healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy - a randomized study comparing ranitidine with esomeprazole | Q46982445 | ||
| Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori | Q47900027 | ||
| A survey of stress ulcer prophylaxis in Intensive Care Units in the UK. | Q48611773 | ||
| Differing patterns of Helicobacter pylori gastritis in patients with duodenal, prepyloric, and gastric ulcer disease. | Q50900413 | ||
| Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. | Q50989183 | ||
| Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis | Q34520598 | ||
| The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs | Q34588716 | ||
| A population-based study of the drug interaction between proton pump inhibitors and clopidogrel | Q34603772 | ||
| American College of Gastroenterology guideline on the management of Helicobacter pylori infection | Q34645482 | ||
| Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori | Q34651921 | ||
| Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail. | Q34657352 | ||
| Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding | Q34714596 | ||
| Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial | Q34720605 | ||
| Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease | Q34721129 | ||
| Bellyaching in these pages: upper gastrointestinal disorders in Psychosomatic medicine | Q34883020 | ||
| ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents | Q34883156 | ||
| Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome | Q34956075 | ||
| Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs | Q35030551 | ||
| Helicobacter pylori infection and perforated peptic ulcer prevalence of the infection and role of antimicrobial treatment. | Q35129759 | ||
| Natural history of gastritis and its relationship to peptic ulcer disease | Q35378921 | ||
| Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial | Q35594930 | ||
| The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population | Q35597205 | ||
| Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults | Q35598340 | ||
| Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users | Q36158848 | ||
| Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. | Q36360546 | ||
| Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis | Q36423165 | ||
| Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin | Q36556507 | ||
| Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients | Q36585284 | ||
| Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. | Q36591918 | ||
| Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial. | Q36820902 | ||
| Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage | Q36904361 | ||
| Helicobacter pylori urease activity is toxic to human gastric epithelial cells. | Q36984967 | ||
| NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon | Q36998760 | ||
| Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin? | Q37044230 | ||
| cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors | Q37047617 | ||
| Cushing's ulcer in traumatic brain injury. | Q37123651 | ||
| Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens | Q38313312 | ||
| Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses. | Q39984099 | ||
| Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only | Q40198420 | ||
| Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: Insight into the mechanism and reversal of NSAID-induced gastrointestinal injury | Q40689497 | ||
| P433 | issue | 9699 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1449-1461 | |
| P577 | publication date | 2009-08-13 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Peptic ulcer disease | |
| P478 | volume | 374 |
| Q33800922 | A Five-Year Review of Perforated Peptic Ulcer Disease in Irrua, Nigeria. |
| Q36822599 | A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection |
| Q27318404 | A novel human gastric primary cell culture system for modelling Helicobacter pylori infection in vitro |
| Q38223755 | A review on antiulcer activity of few Indian medicinal plants |
| Q37131899 | ABCG2 in peptic ulcer: gene expression and mutation analysis |
| Q41964170 | Accommodation in a refugee shelter as a risk factor for peptic ulcer bleeding after the Great East Japan Earthquake: a case-control study of 329 patients |
| Q37608408 | Acid-reducing vagotomy is associated with reduced risk of subsequent ischemic heart disease in complicated peptic ulcer: An Asian population study |
| Q89909840 | Activity of Brucea javanica oil emulsion against gastric ulcers in rodents |
| Q35618974 | Administration of trimethoprim-sulphadimidine does not improve healing of glandular gastric ulceration in horses receiving omeprazole: a randomised, blinded, clinical study. |
| Q41060640 | Aggressive Helicobacter pylori-negative peptic ulceration as the initial manifestation of Crohn's disease |
| Q64896713 | Anti-Ulcerogenic Properties of Lycium chinense Mill Extracts against Ethanol-Induced Acute Gastric Lesion in Animal Models and Its Active Constituents. |
| Q38209865 | Anti-ulcer activity of essential oil constituents. |
| Q28544881 | Antisecretory, gastroprotective, antioxidant and anti-Helicobcter pylori activity of zerumbone from Zingiber zerumbet (L.) Smith |
| Q54942641 | Antiulcer Activity and Potential Mechanism of Action of the Leaves of Spondias mombin L. |
| Q59330492 | Antiulcer Agents: From Plant Extracts to Phytochemicals in Healing Promotion |
| Q57175942 | Antiulcer Effect of Honey in Nonsteroidal Anti-Inflammatory Drugs Induced Gastric Ulcer Model in Rats: A Systematic Review |
| Q86043535 | Antiulcerogenic activity of Carica papaya seed in rats |
| Q34660906 | Antiulcerogenic activity of chlorogenic acid in different models of gastric ulcer |
| Q40365967 | Aspirin-induced gastrointestinal damage is associated with an inhibition of epithelial cell autophagy. |
| Q39025644 | Association Between Subtotal Gastrectomy with Billroth II Anastomosis and Coronary Heart Disease |
| Q54258283 | Association between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease: A Single-Center Clinical Study. |
| Q37234658 | Association between Helicobacter pylori seropositivity and mild to moderate COPD: clinical implications in an Asian country with a high prevalence of H. pylori. |
| Q92422418 | Association between Peptic Ulcer Disease and Osteoporosis: The Population-Based Longitudinal Cohort Study in Korea |
| Q64101672 | Association of Diverticulitis with Prolonged Spondyloarthritis: An Analysis of the ASAS-COMOSPA International Cohort |
| Q38671018 | Association of Vagotomy and Decreased Risk of Subsequent Ischemic Stroke in Complicated Peptic Ulcer Patients: an Asian Population Study |
| Q59804258 | Association of gastric and duodenal ulcers with anthropometry and nutrients: Korean National Health and Nutrition Examination Survey (KNHANES II-IV) 2001-2009 |
| Q38610049 | Association of peptic ulcer disease with obesity, nutritional components, and blood parameters in the Korean population |
| Q33822986 | Bacterial load and cytokine profile in patients with cirrhosis following therapy with proton pump inhibitors: a prospective cohort study |
| Q38630807 | Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial |
| Q55007022 | Biopsies in Gastrointestinal Endoscopy: When and How. |
| Q45265821 | Biphasic effects of H. pylori infection on low-dose aspirin-induced gastropathy depending on the gastric acid secretion level. |
| Q36401925 | Capsule endoscopy in nonresponsive celiac disease |
| Q55339635 | Charlson comorbidity index as a predictor of periodontal disease in elderly participants. |
| Q35823648 | Chronic subclinical perforation of a duodenal ulcer presenting with an abdominal abscess in a patient with seronegative rheumatoid arthritis |
| Q57215706 | Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis |
| Q90103197 | Comparison of concomitant therapy versus standard triple-drug therapy for eradication of Helicobacter pylori infection: A prospective open-label randomized controlled trial |
| Q33830207 | Deep-sea water containing selenium provides intestinal protection against duodenal ulcers through the upregulation of Bcl-2 and thioredoxin reductase 1. |
| Q64057319 | Delivery of pancreatic digestive enzymes into the gastrointestinal tract by pancreatic exocrine tissue transplant |
| Q33675495 | Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline |
| Q24188083 | Deprescribing versus continuation of chronic proton pump inhibitor use in adults |
| Q38903118 | Deprescribing versus continuation of chronic proton pump inhibitor use in adults. |
| Q55301374 | Diagnosis of Helicobacter pylori Using Invasive and Noninvasive Approaches. |
| Q58563950 | Diagnostic methods for Helicobacter pylori infection: ideals, options, and limitations |
| Q34552132 | Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure of Helicobacter pylori infection |
| Q26796414 | Differential inflammatory response to Helicobacter pylori infection: etiology and clinical outcomes |
| Q36412892 | Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control Study |
| Q87257986 | Dual Alpha2C/5HT1A Receptor Agonist Allyphenyline Induces Gastroprotection and Inhibits Fundic and Colonic Contractility |
| Q40349208 | Duodenal ulcers, gastric ulcers and Helicobacter pylori |
| Q89121870 | Effect of food on the pharmacokinetics of YH4808, a potassium-competitive acid blocker, after single- and multiple-oral dosing in healthy subjects |
| Q42371575 | Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression |
| Q91896350 | Effectiveness of Opuntia ficus indica L. inermis Seed Oil in the Protection and the Healing of Experimentally Induced Gastric Mucosa Ulcer |
| Q88749997 | Effects and possible mechanisms of Alpinia officinarum ethanol extract on indomethacin-induced gastric injury in rats |
| Q33583991 | Efficacy of Albis for the Prevention of Gastric Mucosal Injury Concomitant with the Use of Low-Dose Aspirin: A Prospective, Randomized, Placebo-Controlled Study |
| Q90115709 | Efficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections |
| Q33564258 | Efficacy of ilaprazole in the treatment of duodenal ulcers: a meta-analysis |
| Q37671220 | Efficacy of proton pump inhibitors for patients with duodenal ulcers: A pairwise and network meta-analysis of randomized controlled trials |
| Q37265110 | Emergency ulcer surgery |
| Q104559092 | Epidemiology changes in peptic ulcer diseases 18 years apart explored from the genetic aspects of Helicobacter pylori |
| Q26784263 | European College of Equine Internal Medicine Consensus Statement--Equine Gastric Ulcer Syndrome in Adult Horses |
| Q35618517 | Evaluation of combined famotidine with quercetin for the treatment of peptic ulcer: in vivo animal study. |
| Q49963082 | Evaluation of risk factors for perforated peptic ulcer |
| Q36473523 | Evidence of the gastroprotective and anti- Helicobacter pylori activities of β-mangostin isolated from Cratoxylum arborescens (vahl) blume |
| Q43146360 | Fast Eating Speed Increases the Risk of Endoscopic Erosive Gastritis in Korean Adults. |
| Q92134195 | Flavonoid-Rich Extract of Dissotis rotundifolia Whole Plant Protects against Ethanol-Induced Gastric Mucosal Damage |
| Q89272501 | Frequency of Celiac Disease in Children with Peptic Ulcers |
| Q41203467 | GC-MS Analysis and Gastroprotective Evaluations of Crude Extracts, Isolated Saponins, and Essential Oil from Polygonum hydropiper L |
| Q87161229 | Gastric antisecretory and cytoprotective effects of hydroalcoholic extracts of Plumeria alba Linn. leaves in rats |
| Q34427454 | Gastric ulcer patients are more susceptible to developing gastric cancer compared with concomitant gastric and duodenal ulcer patients |
| Q64229804 | Gastrointestinal Tract Disorders in Older Age |
| Q27027977 | Gastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatment |
| Q41883221 | Gastroprotective Effect of Oxalis corniculata (Whole Plant) on Experimentally Induced Gastric Ulceration in Wistar Rats |
| Q51744141 | Gastroprotective Mechanism and Ulcer Resolution Effect of Cyrtocarpa procera Methanolic Extract on Ethanol-Induced Gastric Injury. |
| Q43632198 | Gastroprotective activity of the ethanolic extract and hexane phase of Combretum duarteanum Cambess. (Combretaceae). |
| Q34747906 | Gastroprotective and anti-Helicobacter pylori potential of herbal formula HZJW: safety and efficacy assessment |
| Q97645812 | Gastroprotective and anti-inflammatory effects of Prunus cerasus phytochemicals and their possible mechanisms of action |
| Q37483773 | Gastroprotective and ulcer healing effects of essential oil of Hyptis martiusii Benth. (Lamiaceae). |
| Q39357041 | Gastroprotective effect of alpha-pinene and its correlation with antiulcerogenic activity of essential oils obtained from Hyptis species |
| Q34835001 | Gastroprotective effect of desmosdumotin C isolated from Mitrella kentii against ethanol-induced gastric mucosal hemorrhage in rats: possible involvement of glutathione, heat-shock protein-70, sulfhydryl compounds, nitric oxide, and anti-Helicobacte |
| Q58855969 | Gastroprotective effects of hydroethanolic root extract of Arrabidaea brachypoda: Evidences of cytoprotection and isolation of unusual glycosylated polyphenols |
| Q28085329 | Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury |
| Q64095288 | H. pylori eradication with antibiotic treatment causes changes in glucose homeostasis related to modifications in the gut microbiota |
| Q36740047 | Helicobacter Pylori "Test-and-Treat" Strategy for Management of Dyspepsia: A Comprehensive Review |
| Q58555850 | Helicobacter pylori Infection: New Facts in Clinical Management |
| Q34025831 | Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial |
| Q34764772 | Helicobacter pylori research: historical insights and future directions |
| Q38191568 | Helicobacter pylori-negative, non-steroidal anti-inflammatory drug: negative idiopathic ulcers in Asia |
| Q38227090 | Helicobacter pylori: perspectives and time trends |
| Q39588933 | Helicobacter pylori Eradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy |
| Q36715131 | High Recurrence Rate of Idiopathic Peptic Ulcers in Long-Term Follow-up |
| Q33692873 | Histopathologic and immunohistochemical sequelae of bariatric embolization in a porcine model |
| Q48948199 | Human Lysozyme Synergistically Enhances Bactericidal Dynamics and Lowers the Resistant Mutant Prevention Concentration for Metronidazole to Helicobacter pylori by Increasing Cell Permeability. |
| Q92335973 | In vivo acute toxicity and anti-gastric evaluation of a novel dichloro Schiff base: Bax and HSP70 alteration |
| Q48553450 | Increased adrenocortical response to adrenocorticotropic hormone (ACTH) in sport horses with equine glandular gastric disease (EGGD). |
| Q43246650 | Increasing gastric juice pH level prior to anti-Helicobacter pylori therapy may be beneficial to the healing of duodenal ulcers |
| Q24617429 | Induction of microRNA-155 is TLR- and type IV secretion system-dependent in macrophages and inhibits DNA-damage induced apoptosis |
| Q51324862 | Inhibition of H. pylori colonization and prevention of gastritis in murine model. |
| Q47122744 | Insect tea attenuates hydrochloric acid and ethanol-induced mice acute gastric injury |
| Q34663572 | Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: old question new insights |
| Q34432155 | Investigation of -308G>A and -1031T>C polymorphisms in the TNFA promoter region in Polish peptic ulcer patients. |
| Q51280921 | Isolation, characterization, and in silico, in vitro and in vivo antiulcer studies of isoimperatorin crystallized from Ostericum koreanum. |
| Q26799430 | Kyoto global consensus report on Helicobacter pylori gastritis |
| Q42068748 | Laparoscopic and Open Surgical Treatment in Gastroduodenal Perforations: Our Experience. |
| Q64292553 | Lipopolysaccharides From Non-Helicobacter pylori Gastric Bacteria Potently Stimulate Interleukin-8 Production in Gastric Epithelial Cells |
| Q37625235 | Long-term prognosis in patients continuing taking antithrombotics after peptic ulcer bleeding |
| Q35038558 | Low-dose aspirin-associated upper gastric and duodenal ulcers in Japanese patients with no previous history of peptic ulcers |
| Q55021135 | MUC1 and MUC5AC Acting on Helicobacter pylori-Related Deficiency and Solid Syndrome of Spleen and Stomach. |
| Q37260543 | Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients--focus on esomeprazole |
| Q40311911 | Manuka Honey Exerts Antioxidant and Anti-Inflammatory Activities That Promote Healing of Acetic Acid-Induced Gastric Ulcer in Rats |
| Q35934917 | Mechanism(s) of action underlying the gastroprotective effect of ethyl acetate fraction obtained from the crude methanolic leaves extract of Muntingia calabura |
| Q34874988 | Medical risk factors associated with cholangiocarcinoma in Taiwan: a population-based case-control study |
| Q24186004 | Medical versus surgical treatment for refractory or recurrent peptic ulcer |
| Q24186307 | Medical versus surgical treatment for refractory or recurrent peptic ulcer |
| Q91904061 | Microbiota of the Oropharynx and Endoscope Compared to the Esophagus |
| Q43847498 | Mortality in perforated duodenal ulcer depends upon pre-operative risk: a retrospective 10-year study |
| Q37800342 | NSAID-induced gastrointestinal and cardiovascular injury |
| Q34776122 | No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: a cross-sectional study of 8,013 healthy subjects in Japan |
| Q42244383 | Non-steroidal anti-inflammatory drug-induced enteropathy |
| Q37012409 | Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials |
| Q38974392 | Nonsteroidal Anti-Inflammatory Drug-Induced Gastroduodenal Bleeding: Risk Factors and Prevention Strategies |
| Q57296551 | Nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Cascade Guideline |
| Q94321822 | N‐acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication |
| Q92590152 | Obesity and Risk of Peptic Ulcer Disease: A Large-Scale Health Check-Up Cohort Study |
| Q37768159 | Optimal management of peptic ulcer disease in the elderly |
| Q38107179 | Optimizing the use of aspirin for cardiovascular prevention |
| Q33707944 | Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases |
| Q41305265 | Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users. |
| Q35753673 | Peptic Ulcer Disease in Healthcare Workers: A Nationwide Population-Based Cohort Study |
| Q50167519 | Peptic Ulcers in Fukushima Prefecture Related to the Great East Japan Earthquake, Tsunami and Nuclear Accident |
| Q37549220 | Peptic ulcer disease risk in chronic kidney disease: ten-year incidence, ulcer location, and ulcerogenic effect of medications. |
| Q43460057 | Peptic ulcer disease: further work is required to reduce inequalities |
| Q40118516 | Peptic ulcers accompanied with gastrointestinal bleeding, pylorus obstruction and cholangitis secondary to choledochoduodenal fistula: A case report |
| Q41973384 | Peptic ulcers after the Great East Japan earthquake and tsunami: possible existence of psychosocial stress ulcers in humans |
| Q37328142 | Perforated duodenal ulcer presenting with a subphrenic abscess revealed by plain abdominal X-ray films and confirmed by multi-detector computed tomography: a case report. |
| Q28084426 | Perforated peptic ulcer |
| Q64917613 | Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study. |
| Q92063898 | Pharmacological Effects and Toxicogenetic Impacts of Omeprazole: Genomic Instability and Cancer |
| Q38804396 | Pharmacological reports about gastroprotective effects of methanolic extract from leaves of Solidago chilensis (Brazilian arnica) and its components quercitrin and afzelin in rodents |
| Q38848225 | Potential role of probiotics in the management of gastric ulcer |
| Q36591044 | Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes |
| Q55095896 | Propolis and Its Potential to Treat Gastrointestinal Disorders. |
| Q35116152 | Protective effects of (1-(4-hydroxy-phenyl)-3-m-tolyl-propenone chalcone in indomethacin-induced gastric erosive damage in rats |
| Q47159334 | Protective effects of hot spring water drinking and radon inhalation on ethanol-induced gastric mucosal injury in mice |
| Q94326811 | Proton pump inhibitor‐ and fluoroquinolone‐based triple therapies for eradication |
| Q41996131 | Proton-pump inhibitors: understanding the complications and risks |
| Q36616851 | Quadruple therapy for eradication of Helicobacter pylori |
| Q34299125 | Randomized controlled trial comparing 7-day triple, 10-day sequential, and 7-day concomitant therapies for Helicobacter pylori infection |
| Q64890427 | Reconsidering the Role of Cyclooxygenase Inhibition in the Chemotherapeutic Value of NO-Releasing Aspirins for Lung Cancer. |
| Q49911269 | Refractory gastric antral ulcers without Helicobacter pylori infection and non-steroidal anti-inflammatory drugs |
| Q47801037 | Relationship between Adverse Gastric Reactions and the Timing of Enteric-Coated Aspirin Administration |
| Q28538491 | Rhamnogalacturonan from Acmella oleracea (L.) R.K. Jansen: gastroprotective and ulcer healing properties in rats |
| Q42852402 | Risk factors for development and recurrence of peptic ulcer disease |
| Q37661702 | Risk factors for intestinal metaplasia in concomitant gastric and duodenal ulcer disease |
| Q34255432 | Role of Helicobacter pylori infection on nutrition and metabolism |
| Q28088459 | Role of dietary polyphenols in the management of peptic ulcer |
| Q37616472 | Salivary enzymes in peptic ulcer disease |
| Q90307705 | Sarcopenia is Independently Associated with an Increased Risk of Peptic Ulcer Disease: A Nationwide Population-Based Study |
| Q50217701 | Secretagogue-dependent and -independent transport of zinc hydration forms in rat parietal cells |
| Q48225195 | Sequential versus concomitant therapy for treatment of Helicobacter pylori infection: an updated systematic review and meta-analysis |
| Q64226721 | Serum protein expression in Equine Glandular Gastric Disease (EGGD) induced by phenylbutazone |
| Q33612306 | Statin Therapy Is Associated with Reduced Risk of Peptic Ulcer Disease in the Taiwanese Population |
| Q61447265 | Statins and gastroduodenal endoscopic lesions: A case-control study |
| Q35239157 | Study of the Gastroprotective Effect of Extracts and Semipurified Fractions of Chresta martii DC. and Identification of Its Principal Compounds |
| Q36838164 | Subtotal Gastrectomy With Billroth II Anastomosis Is Associated With a Low Risk of Ischemic Stroke in Peptic Ulcer Disease Patients: A Nationwide Population-Based Study |
| Q90457114 | Surgical repair of perforated peptic ulcers: laparoscopic versus open approach |
| Q88787445 | Synthesis and in vivo anti-ulcer evaluation of some novel piperidine linked dihydropyrimidinone derivatives |
| Q89682811 | Systematic Analysis of Monoterpenes: Advances and Challenges in the Treatment of Peptic Ulcer Diseases |
| Q38001425 | Tannins, peptic ulcers and related mechanisms |
| Q58700546 | Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicen |
| Q40129982 | Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Tr |
| Q34508052 | The 5300-year-old Helicobacter pylori genome of the Iceman |
| Q36205817 | The Development of Diabetes after Subtotal Gastrectomy with Billroth II Anastomosis for Peptic Ulcer Disease |
| Q64093567 | The Interaction of Infection and Type 2 Diabetes Mellitus |
| Q64092764 | The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation |
| Q94571823 | The analysis of risk for peptic ulcer disease using Korean national health and nutrition examination survey: a cross-sectional analysis of a national survey sample |
| Q40073407 | The association between peptic ulcer diseases and mental health problems: A population-based study: a STROBE compliant article |
| Q37071499 | The gastroprotective effect of pogostone from Pogostemonis Herba against indomethacin-induced gastric ulcer in rats. |
| Q35029133 | The prevalence of helicobacter pylori among dyspeptic patients in an earthquake-stricken area |
| Q26784036 | The stomach in health and disease |
| Q33838470 | Therapeutic Applications of Rose Hips from Different Rosa Species. |
| Q38032319 | Therapeutic management of recurrent peptic ulcer disease |
| Q34508830 | Treatment of Helicobacter pylori infection: Past, present and future |
| Q38238745 | Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance |
| Q35647007 | Trends in Peptic Ulcer Disease and the Identification of Helicobacter Pylori as a Causative Organism: Population-based Estimates from the US Nationwide Inpatient Sample |
| Q35132193 | Trends in diagnosis and surgical management of patients with perforated peptic ulcer |
| Q35825245 | Ulcer healing and mechanism(s) of action involved in the gastroprotective activity of fractions obtained from Syngonanthus arthrotrichus and Syngonanthus bisulcatus. |
| Q34062323 | Ulcerogenic Helicobacter pylori strains isolated from children: a contribution to get insight into the virulence of the bacteria |
| Q33893567 | Update on the first-line treatment for Helicobacter pylori infection - a continuing challenge from an old enemy |
| Q27002380 | Upper gastrointestinal microbiota and digestive diseases |
| Q35188639 | Weekly pattern of emergency room admissions for peptic ulcers: a population-based study |
| Q40023559 | When Should Antiplatelet Agents Be Resumed After Successful Endoscopic Hemostasis in Patients with Peptic Ulcer Bleeding? |
Search more.